Abstract
Cytotoxic lymphocytes, including cytotoxic T lymphocytes (CTLs) and natural killer (NK) cells, kill target cells by releasing granules containing perforin and granzymes, and/or via Fas-Fas ligand interactions. Both pathways lead to prompt activation within target cells of caspase cascades responsible for apoptosis induction and cell death. We have utilized cell-permeable fluorogenic caspase substrates and multiparameter flow cytometry to detect caspase activation in target cells, and applied these tools to quantify and visualize cytotoxic lymphocyte activities. This novel assay, referred to as the flow cytometric cytotoxicity (FCC) assay, is a nonradioactive single-cell-based assay that provides a more rapid, biologically informative, and sensitive approach to measure cytotoxic lymphocyte activity when compared to other assays such as the 51chromium (51Cr) release assay. In addition, the FCC assay can be used to study CTL-mediated killing of primary target cells of different cell lineages that are frequently not amenable to study by the 51Cr release assay. Furthermore, the FCC assay enables evaluation of the phenotype and fate of both target and effector cells, and as such, provides a useful new approach to illuminate the biology of cytotoxic lymphocytes.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Meier, P., Finch, A., and Evan, G. (2000) Apoptosis in development. Nature 407, 796–801.
Raulet, D. H., Vance, R. E., and McMahon, C. W. (2001) Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19, 291–330.
Brunner, K. T., Mauel, J., Cerottini, J. C, and Chapuis, B. (1968) Quantitative assay of the lytic action of immune lymphoid cells on 51-Cr-labelled allogeneic target cells in vitro; inhibition by isoantibody and by drugs. Immunology 14, 181–196.
McElrath, M. J., Siliciano, R. F., and Weinhold, K. J. (1997) HIV type 1 vaccine-induced cytotoxic T cell responses in phase I clinical trials: detection, characterization, and quantitation. AIDS Res. Hum. Retroviruses 13, 211–216.
Doherty, P. C. and Christensen, J. P. (2000) Accessing complexity: the dynamics of virus-specific T cell responses. Annu. Rev. Immunol. 18, 561–592.
Nociari, M. M., Shalev, A., Benias, P., and Russo, C. (1998) A novel one-step, highly sensitive fluorometric assay to evaluate cell-mediated cytotoxicity. J. Immunol. Methods 213, 157–167.
Radosevic, K., Garritsen, H. S., Van Graft, M., De Grooth, B. G, and Greve, J. (1990) A simple and sensitive flow cytometric assay for the determination of the cytotoxic activity of human natural killer cells. J. Immunol. Methods 135, 81–89.
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes [published erratum appears in Science 280, 1821 (1998)]. Science 274, 94–96.
Butz, E. A. and Bevan, M. J. (1998) Massive expansion of antigen-specific CD8+ T cells during an acute virus infection. Immunity 8, 167–175.
Maino, V C. and Picker, L. J. (1998) Identification of functional subsets by flow cytometry: intracellular detection of cytokine expression. Cytometry 34, 207–215.
Appay, V, Nixon, D. F., Donahoe, S. M., et al. (2000) HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med. 192, 63–75.
Lee, P. P., Yee, C, Savage, P. A., et al. (1999) Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients. Nat. Med. 5, 677–685.
Zajac, A. J., Blattman, J. N., Murali-Krishna, K., et al. (1998) Viral immune evasion due to persistence of activated T cells without effector function [see comments]. J. Exp. Med. 188, 2205–2213.
Packard, B. Z. and Komoriya, A. (1998) Tumor cell recognition by lymphocytes: is the MHC always essential? Crit. Rev. Immunol. 18, 139–144.
Sheehy, M. E., McDermott, A. B., Furlan, S. N., Klenerman, P., and Nixon, D. F. (2001) A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis [erratum appears in J. Immunol. Methods 252, 219–220 (2001)]. J. Immunol. Methods 249, 99–110.
Lecoeur, H., Fevrier, M., Garcia, S., Riviere, Y., and Gougeon, M. L. (2001) A novel flow cytometric assay for quantitation and multiparametric characterization of cell-mediated cytotoxicity. J. Immunol. Methods 253, 177–187.
Liu, L., Chahroudi, A., Silvestri, G, et al. (2002) Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates. Nat. Med. 8, 185–189.
Packard, B. Z., Toptygin, D. D., Komoriya, A., and Brand, L. (1996) Profluorescent protease substrates: intramolecular dimers described by the exciton model. Proc. Natl. Acad. Sci. USA 93, 11,640–11,645.
Komoriya, A., Packard, B. Z., Brown, M. J., Wu, M. L., and Henkart, P. A. (2000) Assessment of caspase activities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J. Exp. Med. 191, 1819–1828.
Ploegh, H. L. (1998) Viral strategies of immune evasion. Science 280, 248–253.
Xu, X. N., Screaton, G R., Gotch, F. M., et al. (1997) Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells. J. Exp. Med. 186, 7–16.
Restifo, N. P. (2000) Not so Fas: Re-evaluating the mechanisms of immune privilege and tumor escape. Nat. Med. 6, 493–495.
Collins, K. L., Chen, B. K., Kalams, S. A., Walker, B. D., and Baltimore, D. (1998) HIV-1 Nef protein protects infected primary cells against killing by cytotoxic T lymphocytes. Nature 391, 397–401.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Humana Press Inc.
About this protocol
Cite this protocol
Liu, L., Packard, B.Z., Brown, M.J., Komoriya, A., Feinberg, M.B. (2004). Assessment of Lymphocyte-Mediated Cytotoxicity Using Flow Cytometry. In: Hawley, T.S., Hawley, R.G. (eds) Flow Cytometry Protocols. Methods in Molecular Biology™, vol 263. Humana Press. https://doi.org/10.1385/1-59259-773-4:125
Download citation
DOI: https://doi.org/10.1385/1-59259-773-4:125
Publisher Name: Humana Press
Print ISBN: 978-1-58829-234-6
Online ISBN: 978-1-59259-773-4
eBook Packages: Springer Protocols